Hence, the objective of the present article is to establish a clinically relevant cut-off for ferritin levels to define iron deficiency, based on both plasma biomarkers (hepcidin and sTfR) as predictors of iron deficiency. This evidence concerns the gene HAMP and Iron deficiency anemia.